Clinical Trial Update: Vesitirim™ in Men Postmarketing Observational Study

View source ↗

Summary

A postmarketing observational study of Vesitirim in men has completed, evaluating its effects on lower urinary tract symptoms and overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Urinary Tract Symptoms
• Overactive Bladder

Drugs mentioned

• Vesitirim™

Snippet

Sponsor: Astellas Pharma Europe Ltd. | Conditions: Lower Urinary Tract Symptoms (LUTS), Overactive Bladder (OAB) | Status: COMPLETED